Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Umay4women

Financiado

Cerrado

Unique multiarray immunosensor for the accurate quantification of the fertility...

Unique multiarray immunosensor for the accurate quantification of the fertility window of women in saliva Recent data estimate that approximately 8 – 10 % of couples are facing fertility problems which means more than 50 million people worldwide are struggling to get pregnant. One of the main reasons couples have difficulty conceiving... ver más

31/08/2023

UANTWERPEN

178K€

Presupuesto del proyecto: 178K€

Líder del proyecto

UNIVERSITEIT ANTWERPEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-08-31

MSCA-IF-2020: Individual Fellowships

I+D

Cerrada hace 4 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UANTWERPEN

178.32K€ | Lider

DEISTER CONSULTING

457.79K€ | Participante

Proyectos interesantes

BIOCELLPHE

Medical Technol...

Data Science

4M€ Cerrado

DESARROLLO DE UN NUEVO PROTOCOLO DE SELECCIÓN...

Medical Technol...

Nanotechnology

404K€ Cerrado

PID2021-122457OB-I00

Medical Technol...

Nanotechnology

182K€ Cerrado

MicroBeaCh

Medical Technol...

Data Science

196K€ Cerrado

SciFiMed

Medical Technol...

Nanotechnology

4M€ Cerrado

PID2021-124795NB-I00

Medical Technol...

Nanotechnology

327K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 28 meses Fecha Inicio: 2021-04-06
Fecha Fin: 2023-08-31

Líder del proyecto

UNIVERSITEIT ANTWERPEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 178K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Recent data estimate that approximately 8 – 10 % of couples are facing fertility problems which means more than 50 million people worldwide are struggling to get pregnant. One of the main reasons couples have difficulty conceiving is their inability to accurately predict the female’s ovulation period. Indeed, the quantification and monitoring of four specific female hormones is crucial for early identification of infertility and tracing of diseases associated with hormonal disbalances (e.g. ovarian cancer). In comparison with costly and complex conventional methods and commercially available test that only measure one or two of the four key hormones, Umay4women (Umay) proposes, for the first time, a unique and reliable quantification of all hormones involved in the ovulatory cycle to accurately determine the ‘fertility window’ by using non-invasive saliva samples. The novelty of this project relies on the combination of nanomaterials, photosensitizers, paper-based microfluidics and immunoassay disciplines to develop a multiarray biosensor, overcoming the drawbacks of current techniques and sampling methods. Importantly, the sensing strategy is based on a novel photoelectrochemical approach which uses the light to trigger the electrochemical response, thus eliminating potential interferences and empowering the readout. Although initially focused on fertility monitoring in women, the underlying technologies have the potential to be further extended after this fellowship for a wider range of applications and final users (e.g. monitoring of fertility in animal industry or tracing the evolution of patients after ovarian cancer treatment) to develop reliable, low-cost, multiarray platforms for healthcare applications. From the clinical perspective, Umay will facilitate the direct and rapid quantification of the key fertility hormones which will lead to faster and private decision-making processes toward an enhancement of the fertility management of each women.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores